Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Pediatr Otorhinolaryngol ; 140: 110523, 2021 Jan.
Article in English | MEDLINE | ID: mdl-33261859

ABSTRACT

INTRODUCTION: Subglottic cysts (SGCs) are a rare cause of laryngeal stenosis that mainly seem to affect preterm infants with an intubation history. PURPOSE: To review the related literature and compare different management protocols for patients presenting SGCs, as well as briefly report our clinical case treated at Verona University Hospital by Pediatric Airways Team. METHODS: The articles resulting from a PubMed and MEDLINE search were analysed and selected using previously established criteria. A systematic review of the selected papers was conducted following PRISMA guidelines. RESULTS: The search yielded 571 related articles; cross-checking of articles led to the identification and exclusion of 239 duplicates. The remaining 332 papers were screened according to previously established eligibility criteria. The final number of selected articles was 13. CONCLUSIONS: Well-planned teamwork, with active collaboration between the ENT specialists, pediatricians and anesthesiologists, is the key to achieve multidisciplinary management of patients diagnosed with SGCs. Long-term follow-up is crucial considering the high recurrence rate of this disease.


Subject(s)
Cysts , Laryngostenosis , Child , Cysts/diagnosis , Cysts/therapy , Glottis , Humans , Infant, Premature , Intubation, Intratracheal , Laryngostenosis/diagnosis , Laryngostenosis/etiology , Laryngostenosis/therapy , Neoplasm Recurrence, Local
2.
Int Rev Neurobiol ; 132: 407-452, 2017.
Article in English | MEDLINE | ID: mdl-28554417

ABSTRACT

Motor symptoms are core features of Parkinson's disease, while nonmotor symptoms are present from the prodromal stage. Management strategies for the motor symptoms of Parkinson's disease have been widely researched and there have been many advances. Therapy has evolved from oral therapy to once a day to nonoral strategies, both for rescue and for infusion therapy. Treatment for nonmotor symptoms, however, has remained a key unmet need, although of late evidence base for management of some nonmotor symptoms such as pain, dementia, aspects of sleep dysfunction, and constipation has emerged. However, management of many nonmotor symptoms such as anxiety, apathy, fatigue, and insomnia remains uncharted. In this review, we address these management strategies and discuss the evidence base of available therapies.


Subject(s)
Antiparkinson Agents/administration & dosage , Parkinson Disease/drug therapy , Parkinson Disease/physiopathology , Psychotropic Drugs/administration & dosage , Humans , Parkinson Disease/complications
SELECTION OF CITATIONS
SEARCH DETAIL
...